Cancer Associated Fibroblast Marker

The tumor microenvironment (TME) has been shown to play an important role in tumor initiation, development, and metastasis. Numerous factors contribute to the nature of the TME such as the presence of immune cells; T-cells, B-cells, and natural killer (NK) cells, and wider environmental factors, such as extracellular matrix (ECM) stiffness, hypoxia, and interstitial pressure. Amongst all these various factors, fibroblasts have been suggested to play a key role in tumor development.

Fibroblasts have been studied extensively, however, much regarding their influence on the TME remains to be understood. During tumor development, a subpopulation of hyper-activated fibroblasts become prominent in the TME and secretion of cytokines and chemokines from these cells promotes pro-tumorigenic activity. These highly heterogeneous fibroblast populations are known collectively as CAFs (Cancer Associated Fibroblasts).

Due to high plasticity and variability within CAF populations it has been difficult for researchers to define a universal marker for these cells. In lieu of a single marker, a number of markers are currently used to investigate CAFs. PDGFRα and PDGFRβ are common markers used for fibroblast identification, although PDGFRα is more widely expressed over the larger fibroblast populations. α-Smooth Muscle Actin is widely used to identify CAFs, however, some reports suggest it is not expressed by all functionally active CAFs. FSP-1/S100A4 is expressed by cells of mesenchymal origins. Although commonly used as a CAF marker, it too is not expressed by all fibroblasts present in a tumor. Some reports even suggest it to be a marker for quiescent fibroblasts. Fibroblast Activation Protein, or FAP as it is more commonly known, has traditionally been associated with tissue repair, fibrosis, and extracellular matrix degradation. FAP has more recently been described as a useful marker of CAFs. Vimentin strongly characterizes cells of a mesenchymal phenotype. It is frequently used as one marker of CAFs, but it is important to note that it is also highly expressed in fibroblasts of all types, as well as numerous other cell types, such as macrophages and adipocytes, and by epithelial cells undergoing epithelial-to-mesenchymal transition (EMT).

Antibody Products

TargetCatalog#Product NameApplicationReactivity
Cancer Associated Fibroblast MarkerAMRe21266PDGFR-α Rabbit Monoclonal antibodyWB,IF,IP,ELISAHuman,Mouse,Rat
AMRe21513α smooth muscle actin Rabbit Monoclonal antibodyWB,IHC,IF,IP,ELISAHuman,Mouse,Rat
AMRe21274PDGFR-β Rabbit Monoclonal antibodyWB,IHC,IF,IP,ELISAHuman,Mouse,Rat
AMRe21330Vimentin Rabbit Monoclonal antibodyWB,IHC,IF,IP,ELISAHuman,Mouse,Rat
AMRe10830FAP1 (17O11) Rabbit Monoclonal AntibodyWB,IHC-P,IF-PHuman,Mouse
AMRe02564S100A4 Rabbit Monoclonal AntibodyWB,IHC-F,IHC-P,ICC/IF,IPHuman
APS0635HRP-conjugated Polyclonal Goat Anti-Rabbit IgG(H+L) Secondary AntibodyELISA, WB, Dot blotRabbit
AMRe80004GAPDH (12R9) Rabbit Monoclonal AntibodyWB,ELISAHuman,Mouse,Rat,Rabbit,Dog,Monkey
References
  • LeBleu, V.S. and Kalluri, R. (2018) Dis Model Mech 11, pii: dmm029447. doi: 10.1242/dmm.029447.
  • Nurmik, M. et al. (2019) Int J Cancer, doi: 10.1002/ijc.32193.

Voisey 

Voisey is a technical support specialist at EnkiLife, proficient in immunology and cell biology. She is  committed to providing customers with professional and efficient technical support. Additionally, she  is involved in research on customers' fields of study and designs highly cost-effective solutions for them.